Literature DB >> 32387323

Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019.

Matthew J Blitz1, Amos Grünebaum2, Asma Tekbali2, Eran Bornstein2, Burton Rochelson2, Michael Nimaroff2, Frank A Chervenak2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32387323      PMCID: PMC7204719          DOI: 10.1016/j.ajog.2020.05.004

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.

Objective

Early reports indicate that pregnant women are not at an increased risk for coronavirus disease 2019 (COVID-19) or for a worse disease course if infection occurs.1, 2, 3 This study aimed to review our experiences with intensive care unit (ICU) admissions of women of reproductive age with COVID-19, and to determine whether pregnant women are more likely to be admitted to the ICU than nonpregnant women.

Study Design

We evaluated data from a large hospital system in New York State between March 2, 2020, and April 9, 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing was performed on acutely symptomatic patients presenting with characteristic respiratory signs and symptoms. Nasopharyngeal specimens were obtained, and microbiologic diagnosis was made on the basis of a positive result on SARS-CoV-2 real-time reverse transcription polymerase chain reaction (RT-PCR) assay. We included only patients of reproductive age (15–49 years) who were admitted to 1 of 7 hospitals in our system and who received a diagnosis of COVID-19 by RT-PCR on admission, during the hospital stay, or during the postpartum period. Data analyzed in this study included age (5 age groups between 15 and 49 years), pregnancy status, and admission to an ICU. We excluded patients with incomplete data. The incidence of ICU admission was compared between pregnant and nonpregnant women with COVID-19 in each age group. Patients were admitted to the ICU at the discretion of the consulted critical care attending physician. Other clinical characteristics, including medical comorbidities, were not evaluated and not necessarily the same. The institutional review board determined that this study did not meet the definition of human subjects research and was exempt from formal review.

Results

Among all patients between the ages of 15–49 years admitted at 7 hospitals within our health system between March 4, 2020, and April 9, 2020, there were 1168 symptomatic patients who received a diagnosis of COVID-19. Of these, 754 (64.6%) were male, 332 (28.4%) were nonpregnant females, and 82 (7.0%) were pregnant females. During this time period, 2971 pregnant patients were admitted, primarily for delivery. In some cases, symptomatic patients with a diagnosis of COVID-19 (2.8%) were admitted for obstetrical indications and only had mild respiratory disease. In all, 50 nonpregnant females (15.1%, 50 of 332) and 8 pregnant females (9.8%, 8 of 82) were admitted to the ICU for worsening respiratory status, with no statistically significant difference (P=.22). ICU admissions by age group are presented in the Table .
Table

ICU admissions by age group in pregnant and nonpregnant women with COVID-19

Age group, yPregnant women (n=82)Nonpregnant women (n=332)P value
<251/11 (9.1)3/7 (42.9).09
25–290/17 (0)5/40 (12.5).16
30–342/33 (6.1)5/44 (11.4).46
35–393/15 (20.0)9/55 (16.4).73
40–492/6 (33.3)28/190 (14.7).28
Total8/82 (9.8)50/332 (15.1).22

Values are presented as n/N (%).

COVID-19, coronavirus disease 2019; ICU, intensive care unit.

Blitz. ICU admissions for pregnant and nonpregnant women with COVID-19. Am J Obstet Gynecol 2020.

ICU admissions by age group in pregnant and nonpregnant women with COVID-19 Values are presented as n/N (%). COVID-19, coronavirus disease 2019; ICU, intensive care unit. Blitz. ICU admissions for pregnant and nonpregnant women with COVID-19. Am J Obstet Gynecol 2020.

Conclusion

Among hospitalized women who received a diagnosis of COVID-19, pregnant women were not at an increased risk for ICU admission compared with nonpregnant women. This finding is consistent with the overall lower hospital admission rate of pregnant women with COVID-19 that we previously reported. Pregnant women are considered to be at a greater risk of severe morbidity and mortality from other respiratory infections such as influenza. Admission to the ICU signifies a more severe course of disease. Therefore, our findings are reassuring and indicate that pregnant women with COVID-19 may not experience more severe disease progression than nonpregnant women.
  5 in total

Review 1.  Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.

Authors:  Sonja A Rasmussen; John C Smulian; John A Lednicky; Tony S Wen; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2020-02-24       Impact factor: 8.661

Review 2.  Pregnancy and susceptibility to infectious diseases.

Authors:  Elisabeth Sappenfield; Denise J Jamieson; Athena P Kourtis
Journal:  Infect Dis Obstet Gynecol       Date:  2013-07-07

3.  Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York.

Authors:  Asma Tekbali; Amos Grünebaum; Abraham Saraya; Laurence McCullough; Eran Bornstein; Frank A Chervenak
Journal:  Am J Obstet Gynecol       Date:  2020-04-15       Impact factor: 10.693

4.  Coronavirus disease 2019 during pregnancy: a systematic review of reported cases.

Authors:  Anna Nunzia Della Gatta; Roberta Rizzo; Gianluigi Pilu; Giuliana Simonazzi
Journal:  Am J Obstet Gynecol       Date:  2020-04-18       Impact factor: 10.693

5.  Coronavirus disease 2019 in pregnant women: a report based on 116 cases.

Authors:  Jie Yan; Juanjuan Guo; Cuifang Fan; Juan Juan; Xuechen Yu; Jiafu Li; Ling Feng; Chunyan Li; Huijun Chen; Yuan Qiao; Di Lei; Chen Wang; Guoping Xiong; Fengyi Xiao; Wencong He; Qiumei Pang; Xiaoling Hu; Suqing Wang; Dunjin Chen; Yuanzhen Zhang; Liona C Poon; Huixia Yang
Journal:  Am J Obstet Gynecol       Date:  2020-04-23       Impact factor: 10.693

  5 in total
  32 in total

Review 1.  Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study.

Authors:  Babak Sayad; Zeinab Mohseni Afshar; Feizollah Mansouri; Mehdi Salimi; Ronak Miladi; Somayeh Rahimi; Zohreh Rahimi; Maria Shirvani
Journal:  Int J Fertil Steril       Date:  2022-05-08

2.  Effects of Maternal Abdominal Surgery on Fetal Brain Development in the Rabbit Model.

Authors:  Tom Bleeser; Lennart Van Der Veeken; Sarah Devroe; Simen Vergote; Doaa Emam; Johannes van der Merwe; Elina Ghijsens; Luc Joyeux; David Basurto; Marc Van de Velde; Jan Deprest; Steffen Rex
Journal:  Fetal Diagn Ther       Date:  2021-02-25       Impact factor: 2.208

3.  Identifying and combating the impacts of COVID-19 on malaria.

Authors:  Stephen J Rogerson; James G Beeson; Moses Laman; Jeanne Rini Poespoprodjo; Timothy William; Julie A Simpson; Ric N Price
Journal:  BMC Med       Date:  2020-07-30       Impact factor: 8.775

4.  Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2.

Authors:  Aya Mohr-Sasson; Jennifer Chayo; Yossi Bart; Raanan Meyer; Eyal Sivan; Shali Mazaki-Tovi; Yoav Yinon
Journal:  Arch Gynecol Obstet       Date:  2020-06-22       Impact factor: 2.344

Review 5.  Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review.

Authors:  Rommy H Novoa; Willy Quintana; Pedro Llancarí; Katherine Urbina-Quispe; Enrique Guevara-Ríos; Walter Ventura
Journal:  Travel Med Infect Dis       Date:  2020-11-19       Impact factor: 6.211

6.  Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features.

Authors:  Patricia Zadorosnei Rebutini; Aline Cristina Zanchettin; Emanuele Therezinha Schueda Stonoga; Daniele Margarita Marani Prá; André Luiz Parmegiani de Oliveira; Felipe da Silva Dezidério; Aline Simoneti Fonseca; Júlio César Honório Dagostini; Elisa Carolina Hlatchuk; Isabella Naomi Furuie; Jessica da Silva Longo; Bárbara Maria Cavalli; Carolina Lumi Tanaka Dino; Viviane Maria de Carvalho Hessel Dias; Ana Paula Percicote; Meri Bordignon Nogueira; Sonia Mara Raboni; Newton Sergio de Carvalho; Cleber Machado-Souza; Lucia de Noronha
Journal:  Front Immunol       Date:  2021-05-26       Impact factor: 7.561

7.  Are clinical outcomes worse for pregnant women at ≥20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching.

Authors:  Dominique A Badr; Jérémie Mattern; Andrew Carlin; Anne-Gaël Cordier; Evelyne Maillart; Larissa El Hachem; Hanane El Kenz; Marc Andronikof; David De Bels; Charles Damoisel; Thierry Preseau; Dorothée Vignes; Mieke M Cannie; Christelle Vauloup-Fellous; Jean-François Fils; Alexandra Benachi; Jacques C Jani; Alexandre J Vivanti
Journal:  Am J Obstet Gynecol       Date:  2020-07-27       Impact factor: 8.661

8.  COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission.

Authors:  Elicia Pettirosso; Michelle Giles; Stephen Cole; Megan Rees
Journal:  Aust N Z J Obstet Gynaecol       Date:  2020-08-10       Impact factor: 1.884

9.  Clinical profile, viral load, management and outcome of neonates born to COVID 19 positive mothers: a tertiary care centre experience from India.

Authors:  Pratima Anand; Anita Yadav; Pradeep Debata; Sumitra Bachani; Nitesh Gupta; Rani Gera
Journal:  Eur J Pediatr       Date:  2020-09-10       Impact factor: 3.860

Review 10.  Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease.

Authors:  Albert L Hsu; Minhui Guan; Eric Johannesen; Amanda J Stephens; Nabila Khaleel; Nikki Kagan; Breanna C Tuhlei; Xiu-Feng Wan
Journal:  J Med Virol       Date:  2020-11-10       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.